Does inflammatory kynurenine activation with elevated quinolinic acid increase lipid mediator demand and membrane fatty-acid turnover?

Systemic inflammation upregulates the kynurenine pathway, leading to metabolic alterations that can impact cellular membrane integrity and lipid signaling. For older adults, understanding these pathways highlights how chronic inflammatory cascades interface with lipid biology.

Mechanistic pathways

• NMDA activation and calcium influx: Inflammatory cytokines (including IFN-γ, TNF-α, and IL-6) upregulate indoleamine 2,3-dioxygenase (IDO) and kynurenine monooxygenase (KMO), causing an accumulation of quinolinic acid (QUIN). QUIN acts as an NMDA receptor agonist, initiating a substantial influx of intracellular calcium ($Ca^{2+}$).
• Phospholipase A2 activation: The resulting cytosolic calcium surge drives the translocation and activation of calcium-dependent cytosolic phospholipase A2 ($cPLA_2$) to cellular membranes.
• Membrane fatty-acid turnover: Activated $cPLA_2$ hydrolyzes membrane phospholipids at the sn-2 position, liberating free fatty acids like arachidonic acid. This deacylation, combined with QUIN-mediated lipid peroxidation—driven by mitochondrial reactive oxygen species and QUIN-$Fe^{2+}$ Fenton-like reactions—rapidly accelerates membrane fatty-acid degradation and turnover.

Lipid mediator demand

• Eicosanoid synthesis: The liberation of free arachidonic acid from the cell membrane directly feeds downstream enzymatic pathways. This provides the obligate precursor substrate needed for synthesizing pro-inflammatory eicosanoids and prostaglandins (such as $PGE_2$), thereby increasing the cellular demand for lipid mediators.

Bottom line

• Inflammatory kynurenine pathway activation elevates quinolinic acid, which subsequently drives downstream lipid mediator demand and accelerates membrane fatty-acid turnover. This process is mediated by NMDA-induced calcium influx, $cPLA_2$ activation, and iron-dependent lipid peroxidation.